These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 9280799)

  • 41. [The behavior of some metabolic and instrumental parameters in diabetics with arteriopathy of the lower extremities treated with increasing doses of glucuronyl-glycosaminoglycano-sulfate].
    Marigo S
    Clin Ter; 1980 Jun; 93(5):503-18. PubMed ID: 7428314
    [No Abstract]   [Full Text] [Related]  

  • 42. [Endogenous intoxication syndrome in patients in late stages of obliterating atherosclerosis in vessels of lower extremities].
    Dubikaĭtis AIu; Belotserkovskiĭ MV; Koniukhova SG; Strashnov VI
    Biull Eksp Biol Med; 1993 Feb; 115(2):148-51. PubMed ID: 8043789
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Arteriosclerosis risk factors and extent of lesions in arteriopathy of the lower limbs].
    Aliberti G; D'Erasmo E; Ametrano P; Vecci E
    Medicina (Firenze); 1988; 8(1):47-9. PubMed ID: 3067032
    [No Abstract]   [Full Text] [Related]  

  • 44. Arterial insufficiency in the legs. I. A clinical statistical analysis.
    Mathiesen FR; Larsen EE; Wulff MR
    Acta Chir Scand; 1970; 136(6):477-81. PubMed ID: 5518120
    [No Abstract]   [Full Text] [Related]  

  • 45. [The electrophoretic glycoprotein pattern in chronic obliterating arteriopathy of the lower extremities].
    MONTROSI W; GHIRINGHELLI C; BOSELLI G; GALLO G
    Minerva Cardioangiol; 1957 Oct; 5(10):456-61. PubMed ID: 13503740
    [No Abstract]   [Full Text] [Related]  

  • 46. Intravenous vitamin K as a cause of bright yellow plasma discoloration.
    Karp JK; Piacentino M; Gould JM; Peedin AR
    Transfusion; 2019 Aug; 59(8):2502-2503. PubMed ID: 31374147
    [No Abstract]   [Full Text] [Related]  

  • 47. ApoB/ApoA-I ratio in young patients with ischemic cerebral stroke or peripheral arterial disease.
    Sabino AP; De Oliveira Sousa M; Moreira Lima L; Dias Ribeiro D; Sant'Ana Dusse LM; Das Graças Carvalho M; Fernandes AP
    Transl Res; 2008 Sep; 152(3):113-8. PubMed ID: 18774540
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
    Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
    Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
    [TBL] [Abstract][Full Text] [Related]  

  • 49. First-degree kinship with young coronary artery disease patients markedly increases lipid-level disorders in asymptomatic hypertensives.
    Giannini SD; Diament J; Forti N; Issa JS; Dal Bó C; Fukushima J; Barretto AC
    J Cardiovasc Risk; 1998 Jun; 5(3):141-5. PubMed ID: 10201549
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Determinants of serum HDL-C level in a Tehran urban population: the Tehran Lipid and Glucose Study.
    Azizi F; Raiszadeh F; Salehi P; Rahmani M; Emami H; Ghanbarian A; Hajipour R
    Nutr Metab Cardiovasc Dis; 2002 Apr; 12(2):80-9. PubMed ID: 12189907
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Risk factors of arteriopathy of the lower extremities: lipid and not lipid factors].
    Pintó X; Fiol C; Simeón JM; Capdevila JM; Barjau E; Argimón JM; Moga I; Pujol R
    Med Clin (Barc); 1997 Jun; 109(2):41-4. PubMed ID: 9280799
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical and biochemical parameters of patients with vascular stenosis in the lower extremities in the stage of intermittent claudication].
    Kozlovszky B; Mohácsi A; Bajnok L; Csiba L; Országh I; Fülöp T
    Orv Hetil; 1995 Apr; 136(16):817-22. PubMed ID: 7644187
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.